Neumora Therapeutics Inc.... (NMRA)
Neumora Therapeutics Common Stock Max Pain By Strike
NMRA trades at $1.6, 20.0% below the near-term max pain of $2 expiring Sep 19, 2025 (31 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is falling across expirations ($0.5-$97.5), signaling increased put positioning or downside protection. Key magnetic zone at 2 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Neumora Therapeutics Common Stock Max Pain By Expiry
Max pain for NMRA shows a downward trend from 97.5 to 0.5, indicating bearish sentiment or hedging activity. The 560% spread signals divergent expectations across timeframes. Levels distributed around 1.6. Strong magnetic level at 2 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 2 | 0.40 (24.61%) |
| Oct 17, 2025 | 1.5 | -0.10 (-6.54%) |
| Dec 19, 2025 | 1.5 | -0.10 (-6.54%) |
| Jan 16, 2026 | 1 | -0.60 (-37.69%) |
| Apr 17, 2026 | 0.5 | -1.10 (-68.85%) |
| Dec 18, 2026 | 97.5 | 95.89 (5974.77%) |